CHEBI:102216 - methohexital

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name methohexital
ChEBI ID CHEBI:102216
Definition A barbiturate, the structure of which is that of barbituric acid substituted at N-1 by a methyl group and at C-5 by allyl and 1-methylpent-2-ynyl groups.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:6833
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C14H18N2O3
Net Charge 0
Average Mass 262.30430
Monoisotopic Mass 262.13174
InChI InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)
InChIKey NZXKDOXHBHYTKP-UHFFFAOYSA-N
SMILES CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
Roles Classification
Biological Role(s): drug allergen
Any drug which causes the onset of an allergic reaction.
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
Application(s): intravenous anaesthetic

drug allergen
Any drug which causes the onset of an allergic reaction.
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing methohexital (CHEBI:102216) has role drug allergen (CHEBI:88188)
methohexital (CHEBI:102216) has role intravenous anaesthetic (CHEBI:38877)
methohexital (CHEBI:102216) is a acetylenic compound (CHEBI:73474)
methohexital (CHEBI:102216) is a barbiturates (CHEBI:22693)
methohexital (CHEBI:102216) is conjugate acid of methohexital(1−) (CHEBI:60792)
Incoming methohexital(1−) (CHEBI:60792) is conjugate base of methohexital (CHEBI:102216)
IUPAC Name
1-methyl-5-(1-methylpent-2-yn-1-yl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
INNs Sources
Methohexital ChEBI
Methohexitalum ChemIDplus
Metohexital ChemIDplus
Synonyms Sources
(±)-5-allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid ChemIDplus
5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione NIST Chemistry WebBook
5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione ChEMBL
5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid ChemIDplus
α-DL-1-methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid NIST Chemistry WebBook
Methohexital KEGG COMPOUND
Methohexitone ChemIDplus
Manual Xrefs Databases
1748 DrugCentral
C07844 KEGG COMPOUND
D04985 KEGG DRUG
DB00474 DrugBank
Methohexital Wikipedia
View more database links
Registry Numbers Types Sources
151-83-7 CAS Registry Number KEGG COMPOUND
151-83-7 CAS Registry Number NIST Chemistry WebBook
151-83-7 CAS Registry Number ChemIDplus
89964 Reaxys Registry Number Reaxys
89964 Beilstein Registry Number Beilstein
Citations Waiting for Citations Types Sources
13919899 PubMed citation Europe PMC
20045848 PubMed citation Europe PMC
22330701 PubMed citation Europe PMC
22914630 PubMed citation Europe PMC
22914634 PubMed citation Europe PMC
23164727 PubMed citation Europe PMC
23399487 PubMed citation Europe PMC
23422530 PubMed citation Europe PMC
23813116 PubMed citation Europe PMC
3654008 PubMed citation Europe PMC
6864729 PubMed citation ChEMBL
Last Modified
04 March 2019
General Comment
2010-12-09 A short-acting barbiturate-type general anaesthetic, methohexital is 2-3 times more potent than thiopental but has a shorter duration of action. It is normally administered as the sodium salt.